# Compx International Inc: financial statements, quarterly

CIX · NYSE · CIK 1049606 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cix.md) · [Financials](/companies/cix/financials.md) · [Filings](/companies/cix/filings.md) · [Insiders](/companies/cix/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cix/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [40.4](/filings/0001558370-24-014631.md) | [43.2 d](/filings/0001104659-26-023463.md) | [38.0](/filings/0001558370-25-006501.md) | [35.9](/filings/0001558370-25-010298.md) | [33.7](/filings/0001104659-25-107005.md) | [38.4 d](/filings/0001104659-26-023463.md) | [40.3](/filings/0001104659-26-055645.md) | [40.4](/filings/0001104659-26-090386.md) | [40.0](/filings/0001104659-25-107005.md) | [37.7 d](/filings/0001104659-26-023463.md) | [40.6](/filings/0001104659-26-055645.md) | [43.6](/filings/0001104659-26-090386.md) |
| Cost of revenue | $m | [27.7](/filings/0001558370-24-014631.md) | [29.5 d](/filings/0001104659-26-023463.md) | [28.3](/filings/0001558370-25-006501.md) | [24.7](/filings/0001558370-25-010298.md) | [24.2](/filings/0001104659-25-107005.md) | [27.4 d](/filings/0001104659-26-023463.md) | [28.1](/filings/0001104659-26-055645.md) | [27.5](/filings/0001104659-26-090386.md) | [28.9](/filings/0001104659-25-107005.md) | [25.6 d](/filings/0001104659-26-023463.md) | [27.3](/filings/0001104659-26-055645.md) | [28.1](/filings/0001104659-26-090386.md) |
| Gross profit | $m | [12.6](/filings/0001558370-24-014631.md) | [13.6 d](/filings/0001104659-26-023463.md) | [9.7](/filings/0001558370-25-006501.md) | [11.2](/filings/0001558370-25-010298.md) | [9.5](/filings/0001104659-25-107005.md) | [11.1 d](/filings/0001104659-26-023463.md) | [12.2](/filings/0001104659-26-055645.md) | [12.9](/filings/0001104659-26-090386.md) | [11.0](/filings/0001104659-25-107005.md) | [12.1 d](/filings/0001104659-26-023463.md) | [13.3](/filings/0001104659-26-055645.md) | [15.5](/filings/0001104659-26-090386.md) |
| Selling, general and administrative | $m | [6.1](/filings/0001558370-24-014631.md) | [6.1 d](/filings/0001104659-26-023463.md) | [6.0](/filings/0001558370-25-006501.md) | [6.1](/filings/0001558370-25-010298.md) | [6.1](/filings/0001104659-25-107005.md) | [6.2 d](/filings/0001104659-26-023463.md) | [6.3](/filings/0001104659-26-055645.md) | [6.6](/filings/0001104659-26-090386.md) | [6.3](/filings/0001104659-25-107005.md) | [6.4 d](/filings/0001104659-26-023463.md) | [6.2](/filings/0001104659-26-055645.md) | [6.6](/filings/0001104659-26-090386.md) |
| Operating income | $m | [6.5](/filings/0001558370-24-014631.md) | [7.5 d](/filings/0001104659-26-023463.md) | [3.7](/filings/0001558370-25-006501.md) | [5.1](/filings/0001558370-25-010298.md) | [3.3](/filings/0001104659-25-107005.md) | [4.9 d](/filings/0001104659-26-023463.md) | [5.9](/filings/0001104659-26-055645.md) | [6.3](/filings/0001104659-26-090386.md) | [4.8](/filings/0001104659-25-107005.md) | [5.7 d](/filings/0001104659-26-023463.md) | [7.1](/filings/0001104659-26-055645.md) | [8.9](/filings/0001104659-26-090386.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.9](/filings/0001558370-24-014631.md) | [2.0 d](/filings/0001104659-26-023463.md) | [1.2](/filings/0001558370-25-006501.md) | [1.5](/filings/0001558370-25-010298.md) | [1.1](/filings/0001104659-25-107005.md) | [1.3 d](/filings/0001104659-26-023463.md) | [1.6](/filings/0001104659-26-055645.md) | [1.7](/filings/0001104659-26-090386.md) | [1.3](/filings/0001104659-25-107005.md) | [1.7 d](/filings/0001104659-26-023463.md) | [1.9](/filings/0001104659-26-055645.md) | [2.3](/filings/0001104659-26-090386.md) |
| Net income | $m | [5.8](/filings/0001558370-24-014631.md) | [6.7 d](/filings/0001104659-26-023463.md) | [3.8](/filings/0001558370-25-006501.md) | [4.8](/filings/0001558370-25-010298.md) | [3.5](/filings/0001104659-25-107005.md) | [4.5 d](/filings/0001104659-26-023463.md) | [5.1](/filings/0001104659-26-055645.md) | [5.5](/filings/0001104659-26-090386.md) | [4.2](/filings/0001104659-25-107005.md) | [4.7 d](/filings/0001104659-26-023463.md) | [5.9](/filings/0001104659-26-055645.md) | [7.3](/filings/0001104659-26-090386.md) |
| Diluted EPS | $ per share | [0.47](/filings/0001558370-24-014631.md) | not reported | [0.31](/filings/0001558370-25-006501.md) | [0.39](/filings/0001558370-25-010298.md) | [0.28](/filings/0001104659-25-107005.md) | not reported | [0.42](/filings/0001104659-26-055645.md) | [0.44](/filings/0001104659-26-090386.md) | [0.34](/filings/0001104659-25-107005.md) | not reported | [0.48](/filings/0001104659-26-055645.md) | [0.59](/filings/0001104659-26-090386.md) |
| Basic EPS | $ per share | [0.47](/filings/0001558370-24-014631.md) | not reported | [0.31](/filings/0001558370-25-006501.md) | [0.39](/filings/0001558370-25-010298.md) | [0.28](/filings/0001104659-25-107005.md) | not reported | [0.42](/filings/0001104659-26-055645.md) | [0.44](/filings/0001104659-26-090386.md) | [0.34](/filings/0001104659-25-107005.md) | not reported | [0.48](/filings/0001104659-26-055645.md) | [0.59](/filings/0001104659-26-090386.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: not reported
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [17.6](/filings/0001558370-23-017240.md) | [41.4](/filings/0001558370-25-002264.md) | [51.9](/filings/0001558370-24-007052.md) | [70.2](/filings/0001558370-24-011092.md) | [58.8](/filings/0001558370-24-014631.md) | [60.8](/filings/0001104659-26-023463.md) | [56.1](/filings/0001558370-25-006501.md) | [56.2](/filings/0001558370-25-010298.md) | [46.3](/filings/0001104659-25-107005.md) | [54.1](/filings/0001104659-26-090386.md) | [49.4](/filings/0001104659-26-055645.md) | [52.4](/filings/0001104659-26-090386.md) |
| Current assets | $m | [121](/filings/0001558370-23-017240.md) | [127](/filings/0001558370-25-002264.md) | [122](/filings/0001558370-24-007052.md) | [127](/filings/0001558370-24-011092.md) | [103](/filings/0001558370-24-014631.md) | [105](/filings/0001104659-26-023463.md) | [105](/filings/0001558370-25-006501.md) | [108](/filings/0001558370-25-010298.md) | [97.3](/filings/0001104659-25-107005.md) | [100](/filings/0001104659-26-090386.md) | [100](/filings/0001104659-26-055645.md) | [106](/filings/0001104659-26-090386.md) |
| Total assets | $m | [183](/filings/0001558370-23-017240.md) | [188](/filings/0001558370-25-002264.md) | [182](/filings/0001558370-24-007052.md) | [185](/filings/0001558370-24-011092.md) | [160](/filings/0001558370-24-014631.md) | [163](/filings/0001104659-26-023463.md) | [162](/filings/0001558370-25-006501.md) | [165](/filings/0001558370-25-010298.md) | [154](/filings/0001104659-25-107005.md) | [156](/filings/0001104659-26-090386.md) | [156](/filings/0001104659-26-055645.md) | [162](/filings/0001104659-26-090386.md) |
| Current liabilities | $m | [16.4](/filings/0001558370-23-017240.md) | [17.2](/filings/0001558370-25-002264.md) | [11.4](/filings/0001558370-24-007052.md) | [13.7](/filings/0001558370-24-011092.md) | [13.8](/filings/0001558370-24-014631.md) | [15.8](/filings/0001104659-26-023463.md) | [13.6](/filings/0001558370-25-006501.md) | [14.4](/filings/0001558370-25-010298.md) | [15.2](/filings/0001104659-25-107005.md) | [17.0](/filings/0001104659-26-090386.md) | [14.3](/filings/0001104659-26-055645.md) | [15.8](/filings/0001104659-26-090386.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [165](/filings/0001558370-24-014631.md) | [169](/filings/0001104659-26-023463.md) | [169](/filings/0001558370-25-010298.md) | [170](/filings/0001104659-25-107005.md) | [145](/filings/0001104659-25-107005.md) | [146](/filings/0001104659-26-090386.md) | [148](/filings/0001104659-26-090386.md) | [149](/filings/0001104659-26-090386.md) | [138](/filings/0001104659-25-107005.md) | [139](/filings/0001104659-26-090386.md) | [141](/filings/0001104659-26-090386.md) | [145](/filings/0001104659-26-090386.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.0 d](/filings/0001558370-24-014631.md) | [14.0 d](/filings/0001104659-26-023463.md) | [1.7](/filings/0001558370-25-006501.md) | [9.8 d](/filings/0001558370-25-010298.md) | [4.1 d](/filings/0001104659-25-107005.md) | [7.3 d](/filings/0001104659-26-023463.md) | [(0.1)](/filings/0001104659-26-055645.md) | [4.7 d](/filings/0001104659-26-090386.md) | [6.3 d](/filings/0001104659-25-107005.md) | [12.0 d](/filings/0001104659-26-023463.md) | [(1.2)](/filings/0001104659-26-055645.md) | [7.2 d](/filings/0001104659-26-090386.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001558370-24-014631.md) | [0.6 d](/filings/0001104659-26-023463.md) | [0.3](/filings/0001558370-25-006501.md) | [0.4 d](/filings/0001558370-25-010298.md) | [0.5 d](/filings/0001104659-25-107005.md) | [0.2 d](/filings/0001104659-26-023463.md) | [0.8](/filings/0001104659-26-055645.md) | [1.3 d](/filings/0001104659-26-090386.md) | [1.0 d](/filings/0001104659-25-107005.md) | [0.6 d](/filings/0001104659-26-023463.md) | [0.4](/filings/0001104659-26-055645.md) | [1.1 d](/filings/0001104659-26-090386.md) |
| Dividends paid | $m | [3.1 d](/filings/0001558370-24-014631.md) | [3.1 d](/filings/0001104659-26-023463.md) | [3.7](/filings/0001558370-25-006501.md) | [3.7 d](/filings/0001558370-25-010298.md) | [28.3 d](/filings/0001104659-25-107005.md) | [3.7 d](/filings/0001104659-26-023463.md) | [3.7](/filings/0001104659-26-055645.md) | [3.7 d](/filings/0001104659-26-090386.md) | [16.0 d](/filings/0001104659-25-107005.md) | [3.7 d](/filings/0001104659-26-023463.md) | [3.7](/filings/0001104659-26-055645.md) | [3.7 d](/filings/0001104659-26-090386.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [12.3](/filings/0001558370-23-017240.md) | [12.3](/filings/0001558370-24-007052.md) | [12.3](/filings/0001558370-24-011092.md) | [12.3](/filings/0001558370-24-014631.md) | [12.3](/filings/0001558370-25-006501.md) | [12.3](/filings/0001558370-25-010298.md) | [12.3](/filings/0001104659-25-107005.md) | [12.3](/filings/0001104659-26-055645.md) | [0.0](/filings/0001104659-26-090386.md) | [12.3](/filings/0001104659-25-107005.md) | [12.3](/filings/0001104659-26-055645.md) | [0.0](/filings/0001104659-26-090386.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,336,657 at 2026-07-30, from the cover of the [10-Q filed 2026-08-04](/filings/0001104659-26-090386.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.